Skip to main content

Advertisement

SpringerLink
Log in

The challenge of colorectal cancer prevention in Spain

  • Original Paper
  • Published:
The European Journal of Health Economics Aims and scope Submit manuscript

Abstract

Colorectal cancer (CRC) is the leading cause of all new cancer cases and the second major cause for all cancer deaths in Spain. CRC survival has improved over the past few decades and is now higher than the 5-years European average, but this is associated with improved treatment than to early detection. A number of screening pilot programs have been completed in various regions, likely leading to national implementation in the future. Treatment guidelines have been developed and implemented to set standards and reduce practice variability. Newer treatments are available, including laparoscopic surgery, adjuvant chemotherapy and the use of targeted treatments. Specific programs are in place for rural patients, as well as programs to reduce waiting times. Overall, Spain is aware of the issues raised by CRC oncology management and has acted to improve patient outcomes, adding screening to its arsenal will further impact survival rates.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Fernandez, E., La Vecchia, C., Gonzalez, J.R., Lucchini, F., Negri, E., Levi, F.: Converging patterns of colorectal cancer mortality in Europe. Eur. J. Cancer 41, 430–437 (2005)

    Article  Google Scholar 

  2. Centro Nacional de Epidemiología. Instituto de Salud Carlos III: Cancer Situation in Spain (translated from Spanish). Ministerio de Sanidad y Consumo, Madrid (2005)

  3. González, J.R., Moreno, V., Fernandez, E., Izquierdo, A., Borrás, J., Gispert, R.: Probability of developing and dying from cancer in Catalonia during 1998–2001 (translated from Spanish). Med. Clin. (Barc) 124, 411–414 (2005)

    Google Scholar 

  4. Curado, M.P., Edwards, B., Shin, H.R., et al.: Cancer Incidence in Five Continents, vol. IX. IARC Scientific Publications No 160. IARC, Lyon (2007)

  5. Piñol, V., Andreu, M., Castells, A., Payá, A., Bessa, X., Jover, R.: Frequency of hereditary non-polyposis colorectal cancer and other colorectal cancer familial forms in Spain. A multicenter, prospective, nation-wide study. Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Eur. J. Gastroenterol. Hepatol. 16, 39–45 (2004)

    Article  Google Scholar 

  6. Ferlay, J., Autier, P., Boniol, M., Heanue, M., Colombet, M., Boyle, P.: Estimates of the cancer incidence and mortality in Europe in 2006. Ann. Oncol. 18, 581–592 (2007)

    Article  Google Scholar 

  7. Centro Nacional de Epidemiología. Instituto de Salud Carlos III (2006) Mortality from cancer and other causes in Spain (translated from Spanish). http://www.isciii.es/htdocs/centros/epidemiologia/epi_cancer.jsp

  8. Coleman, M.P., Cuaresma, M., Berrino, F., et al.: Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol. 9, 730–756 (2008)

    Article  Google Scholar 

  9. Verdecchia, A., Francisci, S., Brenner, H., et al.: Recent cancer survival in Europe: a 2000–02 period analysis of EUROCARE-4 data. Lancet Oncol. 8, 784–796 (2000)

    Article  Google Scholar 

  10. Gatta, G., Faivre, J., Capocaccia, R., Ponz de Leon, M.: Survival of colorectal cancer patients in Europe during the period 1978–1989. Eur. J. Cancer 34, 2176–2183 (1998)

    Article  Google Scholar 

  11. Berrino, F., De Angelis, R., Sant, M., et al.: Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995–99: results of the EUROCARE-4 study. Lancet Oncol. 8, 773–783 (2007)

    Article  Google Scholar 

  12. Ferlay, J., Bray, F., Pisani, P., Parkin, D.M.: GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. IARC Cancer Base No. 5. Version 2.0. IARC Press, Lyon (2004)

  13. Decreto 316/1993, de 23 de diciembre, de creación del Registro Poblacional de Cáncer de la Comunidad Autónoma de Canarias (1994) BOC Nº 013. Lunes, 31 de enero de 1994. Disponible en: http://www.gobiernodecanarias.org/boc/1994/013/001.html

  14. Ministerio de Sanidad y Consumo: Cancer Strategy in National Healthcare System (translated from Spanish). Centro de Publicaciones del Ministerio de Sanidad y Consumo, Madrid (2006)

  15. Peris-Bonet, R., García Cano, A., González Ros, V., Navarro Jordán, R., Pardo Romaguera, E.: Chilhood Cancer in Spain. Statistics 1980–2007 (translated from Spanish). Registro Nacional de Tumores Infantiles (RNTI_SEHOP). Universitat de València, Valencia (2008). http://www.rticc.cicancer.org/i/RNTISEOP2008.pdf

  16. Red Temática de Investigación Cooperativa en Cáncer. Registries of poblational tumors (translated from Spanish). Ministerio de Ciencia e Innovación. Instituto de Salud Carlos III. http://www.rticcc.org/articulos/p3/plan-p3-articulo.shtml

  17. Parkin, D.M., Chen, V.W., Ferlay, J., Galceran, J., Storm, H.H., Whelan, S.L. (eds.): Comparability and Quality Control in Cancer Registration. IARC Technical Report No. 19. IARC, Lyon (1994)

  18. Grupo de trabajo de la guía de práctica clínica sobre prevención del cáncer colorectal (2004) Guide of clinical practice of colorectal cancer prevention (translated from Spanish). Asociación Española de Gastroenterología, Sociedad Española de Medicina de Familia y Comunitaria y Centro Cochrane Iberoamericano, Barcelona. http://www.guiasgastro.net

  19. Marzo Castillejo, M., Bellas Beceiro, B., Nuin Villanueva, M.A., Cierco Peguera, P., Moreno Baquerano, M.: Estrategias de prevención del cáncer. Aten Primaria 39, 47–66 (2007). http://www.papps.org

    Google Scholar 

  20. Alianza para la prevención del cáncer de colon. http://www.alianzaprevencioncolon.es

  21. Tárraga, P., García-Olmo, D., Celada, A., García-Molinero, M., Divison, J.A., Casado, C.: Colorectal cancer screening through detection of fecal occult blood in a controlled Elath zone. Rev. Esp. Enferm. Dig. 91, 335–344 (1999)

    Google Scholar 

  22. Sala, M., Castells, A., Bessa, X., Gargallo, L., Piqué, J.M.: Screening for colorectal cancer in Catalonia. Results of a population survey. Gastroenterol. Hepatol. 21, 427–431 (1998)

    Google Scholar 

  23. Pla Director d’Oncologia a Catalunya: Direcció General de Planificació i Avaluació. Departament de Salut, Generalitat de Catalunya, Barcelona (2006)

    Google Scholar 

  24. Plan Oncológico de la Comunidad Valenciana 2007–2010: Conselleria de Sanitat. Generalitat Valenciana (2007). http://www.sp.san.gva.es/DgspWeb/planOncologico/

  25. Instituto Catalán de Oncología. Implantation of the pilot program of colorrectal cancer in Vilafranca del Penedès (translated from Catalan). http://www.iconcologia.net/catala/professionals/pic_cancer/pdf/programapilot.pdf

  26. Programa de Prevención del Cáncer Colorrectal de la Comunidad Valenciana: Consellería de Sanitat. Generalitat Valenciana (2007). http://www.msc.es/organizacion/sns/planCalidadSNS/pdf/excelencia/programaCribadoCancerColorrectal.pdf

  27. Cruzado Quevedo, J.: Pilot program of colorectal cancer in the region of Murcia (translated from Spanish). In: Simposio Avanzando hacia el Cribado del Cáncer Colorrectal en España. Asociación Española de Gastroenterología, Tenerife (2008)

  28. Onco-Guide of Hereditary Cancer and Genetic Counselling: Agència d’Avaluació de Tecnología i Recerca Mèdiques. CatSalut (translated from Spanish). Departament de Salut. Generalitat de Catalunya, Barcelona (2006)

  29. Direcció General de Salut Pública. Conselleria de Sanitat. Generalitat Valenciana. Program of Genetic Counseling of Family Cancer. http://www.sp.san.gva.es/DgspWeb/planOncologico/

  30. Ministerio de Sanidad y Consumo: Public sanitary expediture (1988–2005). Ministerio de Sanidad y Consumo (2007)

  31. Antoñanzas, F., Oliva, J., Velasco, M., Zozaya, N., Lorente, R., López Bastida, J.: Direct and indirect costs of cancer in Spain (translated from Spanish). Cuad. Econ. ICE 72, 281–309 (2006)

  32. Farmaindustria: Memoria Anual 2007. Farmaindustria, Madrid (2008)

    Google Scholar 

  33. Greene, F.L., Fleming, I.D.: American Joint Committee on Cancer Staging manual, 6th edn. Springer, Philadelphia (2002)

    Google Scholar 

  34. Lacy, A.M., Delgado, S., Castells, A., Prins, H.A., Arroyo, V., Ibarzabal, A., et al.: The long-term results of a randomized clinical trial of laparoscopy-assisted versus open surgery for colon cancer. Ann. Surg. 248, 1–7 (2008)

    Article  Google Scholar 

  35. Arteaga-Gonzalez, I., Martin-Malagon, A., Fernandez, E.M., et al.: The use of preoperative endoscopic tattooing in laparoscopic colorectal cancer surgery for endoscopically advanced tumors: a prospective comparative clinical study. World J. Surg. 30, 605–611 (2006)

    Article  Google Scholar 

  36. Winawer, S.J., Zauber, A.G., Ho, M.N., et al.: Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N. Engl. J. Med. 329, 1977–1981 (1993)

    Article  Google Scholar 

  37. Saito, Y., Uraoka, T., Matsuda, T., et al.: Endoscopic treatment of large superficial colorectal tumors: a case series of 200 endoscopic submucosal dissections (with video). Gastrointest. Endosc. 66, 966–973 (2007)

    Article  Google Scholar 

  38. Hurlstone, D.P., Atkinson, R., Sanders, D.S., Thomson, M., Cross, S.S., Brown, S.: Achieving R0 resection in the colorectum using endoscopic submucosal dissection. Br. J. Surg. 94, 1536–1542 (2007)

    Article  Google Scholar 

  39. Lacy, A.M.: Laparoscopic surgery and colorectal cancer (translated from Spanish). In: EM T (ed.) Guías Clínicas de la Asociación Española de Cirugía: Cirugía Endoscópica, pp. 390–394. Arán, Madrid (2003)

  40. Lopez-Bastida, J., Mossialos, E.: Pharmaceutical expenditure in Spain: cost and control. Int. J. Health Serv. 30, 597–616 (2000)

    Article  Google Scholar 

  41. Antoñanzas, F., Oliva, J., Pinillos, M., Juàrez, C.: Economic aspects of the new Spanish laws on pharmaceutical preparations. Eur. J. Health Econ. 8, 297–300 (2007)

    Article  Google Scholar 

Download references

Conflict of interest statement

The authors do not report any conflict of interest associated with this paper.

Author information

Authors and Affiliations

  1. Evaluation and Planning Service, Canary Islands Health Service, Canary Islands, Spain

    Julio Lopez-Bastida

  2. University Hospital Nuestra Señora de la Candelaria, Canary Islands Health Service, Santa Cruz de Tenerife, Spain

    Julio Lopez-Bastida

  3. CIBER Epidemiología y Salud Pública (CIBERESP), Murcia, Spain

    Julio Lopez-Bastida

  4. Canary Islands, University Hospital, Tenerife, Spain

    Begoña Bellas-Beceiro & Enrique Quintero-Carrión

Authors
  1. Julio Lopez-Bastida
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Begoña Bellas-Beceiro
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Enrique Quintero-Carrión
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Julio Lopez-Bastida.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lopez-Bastida, J., Bellas-Beceiro, B. & Quintero-Carrión, E. The challenge of colorectal cancer prevention in Spain. Eur J Health Econ 10 (Suppl 1), 75–83 (2010). https://doi.org/10.1007/s10198-009-0186-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10198-009-0186-x

Keywords

JEL Classification

Search

Navigation